SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-5.65%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$417M
AUM Growth
+$417M
(-11%)
Cap. Flow
-$5.3M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
35.02%
Holding
95
New
14
Increased
26
Reduced
18
Closed
15
Top Buys
| 1 |
Tower Semiconductor
TSEM
|
$7.42M |
| 2 |
Cytokinetics
CYTK
|
$6.89M |
| 3 |
Advanced Micro Devices
AMD
|
$4.97M |
| 4 |
Meta Platforms (Facebook)
META
|
$4.57M |
| 5 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$3.79M |
Top Sells
| 1 |
Nice
NICE
|
$8.5M |
| 2 |
Nova
NVMI
|
$8.21M |
| 3 |
Camtek
CAMT
|
$6.75M |
| 4 |
Praxis Precision Medicines
PRAX
|
$6.69M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$6.02M |
Sector Composition
| 1 | Healthcare | 79.93% |
| 2 | Technology | 10.32% |
| 3 | Consumer Discretionary | 2.91% |
| 4 | Communication Services | 1.1% |
| 5 | Materials | 0.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sanofi
SNY
$121B
| $26.8M | 4.88% | 499,515 -30,000 | -6% | -$1.61M |
|
2
AstraZeneca
AZN
$248B
| $19.3M | 3.52% | 285,060 | – | – |
|
3
Johnson & Johnson
JNJ
$427B
| $14.8M | 2.69% | 94,831 -25,000 | -21% | -$3.89M |
|
4
Merck
MRK
$210B
| $12.7M | 2.32% | 123,600 +3,000 | +2% | +$309K |
|
5
Amazon
AMZN
$2.44T
| $12.1M | 2.21% | 95,300 -29,000 | -23% | -$3.69M |
|
|
6
Tower Semiconductor
TSEM
$6.58B
| $11.5M | 2.1% | 469,574 +302,128 | +180% | +$7.42M |
|
7
Syndax Pharmaceuticals
SNDX
$1.41B
| $11.2M | 2.04% | 773,061 +50,000 | +7% | +$726K |
|
8
Microsoft
MSFT
$3.77T
| $10.9M | 1.98% | 34,442 +130 | +0.4% | +$41K |
|
9
Ultragenyx Pharmaceutical
RARE
$2.89B
| $9.24M | 1.68% | 259,135 +75,439 | +41% | +$2.69M |
|
10
BridgeBio Pharma
BBIO
$9.89B
| $9.11M | 1.66% | 345,537 +23,902 | +7% | +$630K |
|
11
Novo Nordisk
NVO
$251B
| $8.46M | 1.54% | 93,080 +36,540 | +65% | +$3.32M |
|
|
12
Praxis Precision Medicines
PRAX
$958M
| $8.29M | 1.51% | 4,850,317 -3,914,017 | -45% | -$6.69M |
|
13
Eli Lilly
LLY
$657B
| $7.62M | 1.39% | 14,190 -1,500 | -10% | -$806K |
|
14
Madrigal Pharmaceuticals
MDGL
$9.76B
| $7.43M | 1.35% | 50,867 +25,867 | +103% | +$3.78M |
|
|
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
| $7.4M | 1.35% | 319,911 +7,286 | +2% | +$168K |
|
16
Immatics
IMTX
$619M
| $7.15M | 1.3% | 617,173 | – | – |
|
|
SHLT
17
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
| $6.96M | 1.27% | 632,256 -82,317 | -12% | -$906K |
|
|
18
Cytokinetics
CYTK
$4.23B
| $6.89M | 1.26% | +233,933 | New | +$6.89M |
|
19
AbbVie
ABBV
$372B
| $6.86M | 1.25% | 46,000 -10,000 | -18% | -$1.49M |
|
20
Palo Alto Networks
PANW
$127B
| $6.74M | 1.23% | 28,759 +1,759 | +7% | +$412K |
|
21
Biogen
BIIB
$19.4B
| $6.64M | 1.21% | 25,846 +2,000 | +8% | +$514K |
|
22
Day One Biopharmaceuticals
DAWN
$769M
| $6.5M | 1.18% | 530,000 | – | – |
|
23
Kura Oncology
KURA
$686M
| $6.41M | 1.17% | 703,287 +100,000 | +17% | +$912K |
|
24
Alnylam Pharmaceuticals
ALNY
$58.5B
| $6.39M | 1.16% | 36,101 -3,899 | -10% | -$691K |
|
|
25
Nice
NICE
$8.73B
| $6.37M | 1.16% | 37,482 -50,000 | -57% | -$8.5M |
|